Insight Molecular Diagnostics Stock Price Patterns
| IMDX Stock | 4.90 0.01 0.20% |
Momentum
Sell Extended
Oversold | Overbought |
EPS Estimate Current Year -1.15 | EPS Estimate Next Year -0.84 | Wall Street Target Price 8.3333 | EPS Estimate Current Quarter -0.24 | Quarterly Revenue Growth 1.261 |
This section relates Insight Molecular Diagnostics headline activity to recent price behavior and peer context. Options positioning and short interest are used here to outline sentiment for Insight Molecular.
For additional insight, see Dividend Yield and Price To Sales Ratio.
Insight Molecular Implied Volatility | 0.83 |
Insight Molecular's implied volatility reflects the market's expectation for price variability, not direction. This context can be compared with historical volatility and price movement.
The sentiment module for Insight Molecular aggregates news and social attention to provide volatility and performance context.
Insight Molecular after-hype prediction price | $ 4.89 |
Hype signals are presented as complementary context to forecasting, technicals, analyst estimates, earnings, and momentum.
Rule 16 for the current Insight contract - Pricing Context
Using the Rule 16 heuristic, the current implied volatility suggests an average daily move of about 0.0519% for the 2026-04-17 options. This estimate is a volatility reference; at $ 4.90, it implies a move of about $ 0.0025 per day.
Use Insight Molecular Basic Forecasting Models to cross-verify projections for Insight Molecular. This adds a model-based reference for the projection set.The concept of mean reversion suggests that Insight Molecular's price will eventually return toward its long-run average. High prices may deter value investors, while unusually low prices often attract buyers who anticipate a recovery.
After-Hype Price Density Analysis
The price distribution graph for Insight Molecular visualizes the statistical uncertainty around our prediction model's output. Investors should interpret the full distribution of Insight Molecular's outcomes, not just the central tendency, when making decisions.
Next price density |
| Expected price to next headline |
Estimiated After-Hype Price Volatility
The downside and upside margins for Insight Molecular after major news events are estimated from historical precedent. Insight Molecular's after-hype downside and upside margins for the prediction period are 0.24 and 10.49, respectively. This approach captures the empirical distribution of Insight Molecular's short-term price reactions without assuming any particular model of future behavior.
Current Value
The after-hype framework applied to Insight Molecular Diagnostics assumes a 3 months review window and focuses on post-sentiment normalization rather than raw momentum. This view is most useful when investors want to compare sentiment-driven price extension with a more measured post-news scenario.
Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Insight Molecular is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Insight Molecular backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Insight Molecular, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.12 | 5.63 | 0.01 | 0.00 | 8 Events | 7 Events | In 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
4.90 | 4.89 | 0.00 |
|
Hype Timeline
Insight Molecular is currently traded for 4.90. The company has historical hype elasticity of 0.01, and average elasticity to hype of competition of 0.0. Insight is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.12%. %. The volatility of related hype on Insight Molecular is about 46916.67%, with the expected price after the next announcement by competition of 4.90. About 19.0% of the company shares are held by company insiders. The company recorded a loss per share of 3.21. Insight Molecular had not issued any dividends in recent years. The company completed a 1:20 stock split on 25th of July 2023. Given the investment horizon of 90 days the next forecasted press release will be in 8 days. Use Insight Molecular Basic Forecasting Models to cross-verify projections for Insight Molecular. This adds a model-based reference for the projection set.Related Hype Analysis
The relationship between Insight Molecular and its sector peers means that news affecting one company often reverberates across Insight Molecular's competitive landscape. Tracking peer hype helps investors anticipate Insight Molecular's likely short-term price behavior.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CCCC | C4 Therapeutics | 0.19 | 8 per month | 4.58 | 0.04 | 10.99 | -8.03 | 31.18 | |
| SGMO | Sangamo Therapeutics | 0.03 | 10 per month | 0.00 | 0.0017 | 7.89 | -7.50 | 73.25 | |
| CYBN | Cybin Inc | -0.43 | 1 per month | 7.01 | 0.01 | 7.72 | -7.86 | 44.73 | |
| OABI | OmniAb Inc | 0.03 | 10 per month | 0.00 | 0.0017 | 5.29 | -5.50 | 16.00 | |
| PRLD | Prelude Therapeutics | 0.20 | 7 per month | 6.25 | 0.20 | 16.50 | -12.17 | 36.35 | |
| CDXS | Codexis | -0.04 | 8 per month | 0.00 | -0.07 | 7.02 | -7.74 | 24.68 | |
| ARMP | Armata Pharmaceuticals | -0.02 | 1 per month | 4.70 | 0.18 | 14.07 | -7.66 | 34.69 | |
| IVVD | Invivyd | -0.04 | 14 per month | 0.00 | -0.03 | 8.05 | -6.92 | 33.79 | |
| PEPG | PepGen | 0.04 | 7 per month | 5.97 | 0.07 | 10.59 | -9.08 | 36.99 | |
| MIST | Milestone Pharmaceuticals | -0.08 | 10 per month | 0.00 | -0.13 | 5.70 | -6.38 | 28.79 |
Insight Molecular Additional Predictive Modules
Most predictive techniques to examine Insight price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Insight using various technical indicators. When you analyze Insight charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Sentiment Indicators & Methodology
Sentiment analysis for Insight Molecular evaluates news tone, positioning, and narrative momentum. Headline intensity can influence short-horizon pricing dispersion. Insight Molecular has a market cap of 150.59 M, ROE of -236.03%.
For Insight Molecular Diagnostics, this section uses periodic company reporting and market reference feeds with Macroaxis normalization rules applied to keep cross-asset comparisons consistent. Analyst inputs may be included when coverage is available. Intraday timing differences may exist.
This content is curated and reviewed by:
Gabriel Shpitalnik - Member of Macroaxis Editorial BoardAlso Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Popular Tools for Insight Stock analysis
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |